# Pre-emptive Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Postoperative Pain After Craniotomy

> **NCT04078139** · PHASE4 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 188 (estimated)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** The MP/RP group
- **DRUG:** The RP group

## Key facts

- **NCT ID:** NCT04078139
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-05
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2020-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04078139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04078139, "Pre-emptive Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Postoperative Pain After Craniotomy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04078139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*